Fundz

Cancer-Focused Abdera Therapeutics Collects $142M For Series A, B Deals

PRIVATEApr 20, 2023

Amount Raised

$142 Million

Round Type

Series A

Menlo ParkBiotechnologyTherapeuticsBiopharma

Investors

Ven Bio PartnersAmplitude VenturesVersant Ventures

Description

Versant Ventures and Amplitude Ventures led the Series A round, while venBio Partners led the Series B round.

Quick answer

Abdera Therapeutics raised $142 Million in a Series A round, dated April 20, 2023. Investors: Ven Bio Partners, Amplitude Ventures and Versant Ventures. Abdera Therapeutics is based in Menlo Park, California, United States.

How much did Abdera Therapeutics raise?
Abdera Therapeutics raised $142 Million in a Series A round on April 20, 2023.
Who invested in Abdera Therapeutics?
Ven Bio Partners, Amplitude Ventures and Versant Ventures are named as investors in this round.
What does Abdera Therapeutics do?
Abdera Therapeutics is a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable, precision radiopharmaceuticals for cancer.
Where is Abdera Therapeutics based and how big is it?
Abdera Therapeutics is based in Menlo Park, California, United States.
Who are the decision-makers at Abdera Therapeutics?
Fundz holds 1 contact at Abdera Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biopharma around the same time

Companies in the same sectors as Abdera Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Renibus Therapeutics raised $64M on May 25, 2023.
  • OnKure Therapeutics raised $54M (Series C) on May 23, 2023.
  • Decoy Therapeutics Inc. raised $6M on May 11, 2023.
  • Biomica raised $20M (Funding Round) on April 27, 2023.
  • HCW Biologics raised $26M (Debt Financing) on April 27, 2023.
  • Mezzion Pharma raised $40M (Funding Round) on April 25, 2023.

Who to call at Abdera Therapeutics, and when

A new round usually means Abdera Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Abdera Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Abdera Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Abdera Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Abdera Therapeutics

Location

Menlo Park, California, United States

About

Abdera Therapeutics is a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable, precision radiopharmaceuticals for cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Abdera Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Abdera Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Abdera Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.